John Kilcoyne
President & CEO
Raindrop Launch Strategy
RVO 417 Rev 1 14 of 14
Surgeon/Site Selection
Presbyopic Market …The Holy Grail
Presbyopic Emmetrope
+1.0 D to -0.5 D
28.5 Million Patients in US
13.1 Million Patients
With a HHI > $75k in US
Contrary To Popular Belief
2%
1%
26%
34%
37%
Unsure
Other
Current Optometrist
Current Ophthalmologist
Eye Care Professional
Specializing In Procedure
71% Would Seek An Ophthalmologist
RVO 417 Rev 1 12 of 14
Surgeon Growth Opportunity
350 Surgeons Identified
Real World Raindrop Outcomes
99% < 20/20
Binocular Distance
N: 149
78% < J3
Binocular Near
N: 173
2.5% Explant Rate
Surgeon Satisfaction – Q1 2017
Satisfied Not Satisfied
93%
7
N: 93
Surgeon-Surgeon Recommendation – Q1 2017
Recommend Not Recommend
3
97%
N: 93
Patient Satisfaction - HealthLoop
How Satisfied Are You With Your Raindrop Vision?
82%
18%
3 Months
Satisfied Dissatisfied
N = 28
Patient Recommendation - HealthLoop
Have You Recommended Raindrop To Anyone?
65%
35%
3 Months
YES NO
N = 26
Raindrop Reorder Rate
60%
40%
All Accounts
August - March
Reordered
6…
34%
Q1 2017
Vs. August - December
Raindrop Launch Strategy...
Raindrop… Cracking The Code

Ophthalmology Innovation Showcase 2 - ReVision Optics